Related Experiment Video
Updated: Jan 27, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing
N Sicot1, N Khanafer, V Meyssonnier
1National Reference Centre for Staphylococci INSERM U851, Faculté de Médecine Lyon Est, Université de Lyon, Lyon, France.
Abstract:
Staphylococcal necrotizing pneumonia (NP) is a severe disease associated with Panton-Valentine leucocidin (PVL). NP was initially described for methicillin-susceptible Staphylococcus aureus (MSSA) infection, but cases associated with methicillin-resistant S. aureus (MRSA) infection have increased concomitantly with the incidence of community-acquired MRSA worldwide. The role of methicillin resistance in the severity of NP remains controversial. The characteristics and outcomes of 133 patients with PVL-positive S. aureus community-acquired pneumonia (CAP) were compared according to methicillin resistance. Data from patients hospitalized for PVL-positive S. aureus CAP in France from 1986 to 2010 were reported to the National Reference Centre for Staphylococci and were included in the study. The primary end point was mortality. Multivariate logistic modelling and the Cox regression were used for subsequent analyses. We analysed 29 cases of PVL-MRSA and 104 cases of PVL-MSSA pneumonia. Airway haemorrhages were more frequently associated with PVL-MSSA pneumonia. However, no differences in the initial severity or the management were found between these two types of pneumonia. The rate of lethality was 39% regardless of methicillin resistance. By Cox regression analysis, methicillin resistance was not found to be a significant independent predictor of mortality at 7 or 30 days (p 0.65 and p 0.71, respectively). Our study demonstrates that methicillin resistance is not associated with the severity of staphylococcal necrotizing pneumonia.
Insights
Methicillin resistance does not impact the severity of staphylococcal necrotizing pneumonia (NP), a severe disease caused by Panton-Valentine leucocidin (PVL)-positive Staphylococcus aureus. This finding holds true regardless of whether the bacteria are methicillin-susceptible (MSSA) or methicillin-resistant (MRSA).
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Staphylococcal necrotizing pneumonia (NP) is a severe lung infection linked to Panton-Valentine leucocidin (PVL).
- While initially described in methicillin-susceptible S. aureus (MSSA), cases involving methicillin-resistant S. aureus (MRSA) have increased globally.
- The impact of methicillin resistance on NP severity remains debated.
Purpose of the Study:
- To compare the characteristics and outcomes of patients with PVL-positive S. aureus community-acquired pneumonia (CAP) based on methicillin resistance.
- To investigate whether methicillin resistance influences the severity and lethality of staphylococcal NP.
Main Methods:
- Retrospective analysis of 133 patients with PVL-positive S. aureus CAP hospitalized in France (1986-2010).
- Data collected by the National Reference Centre for Staphylococci.
- Comparison between PVL-MRSA (29 cases) and PVL-MSSA (104 cases) pneumonia using multivariate logistic modeling and Cox regression analysis.
Main Results:
- Airway hemorrhages were more common in PVL-MSSA pneumonia.
- No significant differences were observed in initial severity or patient management between PVL-MRSA and PVL-MSSA groups.
- The overall mortality rate was 39% and was not significantly influenced by methicillin resistance.
Conclusions:
- Methicillin resistance is not a significant independent predictor of mortality in staphylococcal NP.
- The severity of staphylococcal necrotizing pneumonia is not associated with methicillin resistance.
More Related Videos
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
What are Populations and Communities?
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Naturalistic Observations
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

